# Staar Surgical Co: Form 10-Q for the period ended Jun 28, 2019

- Company: [Staar Surgical Co](/companies/staa.md) (CIK 718937)
- Form: 10-Q
- Filed: 2019-07-31
- Accepted by EDGAR: Jul 31, 2019, 16:19 ET
- Period: 2019-06-28
- Accession: 0001564590-19-027498
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/718937/000156459019027498/staa-10q_20190628.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/718937/000156459019027498/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-06-28.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-03-30 to 2019-06-28 | $5.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2018-12-29 to 2019-06-28 | $10.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-03-30 to 2019-06-28 | $9.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2018-12-29 to 2019-06-28 | $18.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-03-30 to 2019-06-28 | $29.9m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2018-12-29 to 2019-06-28 | $54.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-03-30 to 2019-06-28 | $6.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2018-12-29 to 2019-06-28 | $11.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-03-30 to 2019-06-28 | $25.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2018-12-29 to 2019-06-28 | $47.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-03-30 to 2019-06-28 | $4.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2018-12-29 to 2019-06-28 | $6.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2019-03-30 to 2019-06-28 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2018-12-29 to 2019-06-28 | $1.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-03-30 to 2019-06-28 | $3.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2018-12-29 to 2019-06-28 | $5.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-03-30 to 2019-06-28 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2018-12-29 to 2019-06-28 | $0.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-03-30 to 2019-06-28 | $0.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2018-12-29 to 2019-06-28 | $0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-03-30 to 2019-06-28 | 46,733,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2018-12-29 to 2019-06-28 | 46,842,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2018-12-29 to 2019-06-28 | $4.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2018-12-29 to 2019-06-28 | $4.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2019-06-28 | $103.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-06-28 | $158.9m | us-gaap:AssetsCurrent |
| Total assets | at 2019-06-28 | $186.0m | us-gaap:Assets |
| Current liabilities | at 2019-06-28 | $28.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-06-28 | $41.6m | us-gaap:Liabilities |
| Shareholders' equity | at 2019-06-28 | $144.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/718937/000156459019027498/staa-10q_20190628.htm

Filed Jul 31, 2019.
Source: SEC EDGAR, the filing index for accession 0001564590-19-027498. Last ingested by Listed: Nov 4, 2026, 17:00 ET. No prices; not investment advice.
